BXN — Bioxyne Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapFalling Star
- AU$8.32m
- AU$6.29m
- AU$2.11m
Annual balance sheet for Bioxyne, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2017 June 30th | C2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.88 | 3.31 | 1.77 | 1.75 | 1.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.537 | 0.684 | 0.779 | 0.318 | 0.364 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.51 | 4.73 | 3.52 | 3.07 | 2.51 |
| Net Property, Plant And Equipment | 0.003 | 0.161 | 0.209 | 0.235 | 0.138 |
| Net Intangible Assets | |||||
| Total Assets | 4.74 | 5.05 | 3.97 | 3.34 | 2.68 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.61 | 0.729 | 0.829 | 0.726 | 0.745 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.61 | 0.729 | 0.882 | 0.779 | 0.798 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.13 | 4.32 | 3.09 | 2.56 | 1.88 |
| Total Liabilities & Shareholders' Equity | 4.74 | 5.05 | 3.97 | 3.34 | 2.68 |
| Total Common Shares Outstanding |